Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rebi ointment
- Development stage
- Preclinical
- Lead developer
- Yunnan Provincial Hospital of Traditional Chinese Medicine
- Administration
- Topical
01
Overview
**Rebi ointment** is a topical traditional Chinese medicine preparation investigated for symptomatic treatment of joint swelling and pain in rheumatoid arthritis with damp-heat syndrome. It was evaluated as an externally applied adjunct to oral methotrexate, leflunomide, and folic acid in the prospective ChiCTR trial ChiCTR2100041821, sponsored by Yunnan Provincial Hospital of Traditional Chinese Medicine. Public trial information does not disclose its active constituents, manufacturer, molecular targets, or a defined pharmacological mechanism.
- Other names
- 热痹膏
Beyond the preview
Go deeper on Rebi ointment.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rebi ointment.